ADMA Biologics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,067.60
5,915.50
7,177.60
10,661.00
22,760.60
16,985.30
Cost of Goods Sold (COGS) incl. D&A
4,441.60
7,593.20
4,311.50
11,808.50
36,902.70
43,039.60
Gross Income
1,374.00
1,677.70
2,866.20
1,147.40
14,142.20
26,054.30
SG&A Expense
13,668.40
14,340.90
18,380.00
16,183.00
20,122.40
30,334.70
EBIT
15,042.40
16,018.50
15,513.80
17,330.40
34,264.60
56,388.90
Unusual Expense
43.30
74.40
651.20
-
6,255.60
3,900
Non Operating Income/Expense
82.50
-
-
4.50
10.10
127.10
Interest Expense
618.20
1,286.20
1,842.70
2,239.60
3,285.80
5,522.80
Pretax Income
15,527.20
17,364.90
17,969.90
19,515.20
43,759.00
65,743.40
Income Tax
-
551.70
-
-
-
-
Consolidated Net Income
15,527.20
16,813.20
17,969.90
19,515.20
43,759.00
65,743.40
Net Income
15,527.20
16,813.20
17,969.90
19,515.20
43,759.00
65,743.40
Net Income After Extraordinaries
15,527.20
16,813.20
17,969.90
19,515.20
43,759.00
65,743.40
Net Income Available to Common
15,527.20
16,813.20
17,969.90
19,515.20
43,759.00
65,743.40
EPS (Basic)
2.38
1.81
1.73
1.61
1.91
1.45
Basic Shares Outstanding
6,531.00
9,291.80
10,412.30
12,153.40
22,896.00
45,188.90
EPS (Diluted)
2.38
1.81
1.73
1.61
1.91
1.45
Diluted Shares Outstanding
6,531.00
9,291.80
10,412.30
12,153.40
22,896.00
45,188.90
EBITDA
14,831.80
15,770.70
15,044.00
16,860.80
31,572.30
52,942.50
Non-Operating Interest Income
7.60
14.20
37.80
50.30
57.20
195.40
About ADMA Biologics
View Profile
